[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Market Updates by ScanX [@mupdatesbyscanx](/creator/twitter/mupdatesbyscanx) on x XXX followers Created: 2025-07-21 14:10:47 UTC Cipla (CIPLA) on NSE: 1473.90 (-0.57%) Cipla Strengthens Respiratory Healthcare with ₹5 Crore Investment in Icaltech Innovations View: Positive Cipla Limited has announced a strategic investment of ₹5 crore to acquire a XX% stake in Icaltech Innovations Private Limited, a Bangalore-based medical devices company specializing in respiratory care diagnostics. The investment involves subscribing to 1,50,820 optionally convertible preference shares and X equity share. This move aims to strengthen Cipla's position in respiratory healthcare and expand its diagnostic solutions portfolio. The collaboration is expected to leverage synergies between Cipla's pharmaceutical expertise and Icaltech's medical device technologies. Icaltech has shown significant growth, with its turnover increasing from ₹1.28 crore in FY 2022-23 to ₹6.70 crore projected for FY 2024-25. Read more: #Stocks #Market #CIPLA  XX engagements  **Related Topics** [investment](/topic/investment) [coins healthcare](/topic/coins-healthcare) [$ciplans](/topic/$ciplans) [Post Link](https://x.com/mupdatesbyscanx/status/1947298213771587941)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Market Updates by ScanX @mupdatesbyscanx on x XXX followers
Created: 2025-07-21 14:10:47 UTC
Cipla (CIPLA) on NSE: 1473.90 (-0.57%)
Cipla Strengthens Respiratory Healthcare with ₹5 Crore Investment in Icaltech Innovations
View: Positive
Cipla Limited has announced a strategic investment of ₹5 crore to acquire a XX% stake in Icaltech Innovations Private Limited, a Bangalore-based medical devices company specializing in respiratory care diagnostics. The investment involves subscribing to 1,50,820 optionally convertible preference shares and X equity share. This move aims to strengthen Cipla's position in respiratory healthcare and expand its diagnostic solutions portfolio. The collaboration is expected to leverage synergies between Cipla's pharmaceutical expertise and Icaltech's medical device technologies. Icaltech has shown significant growth, with its turnover increasing from ₹1.28 crore in FY 2022-23 to ₹6.70 crore projected for FY 2024-25.
Read more:
#Stocks #Market #CIPLA
XX engagements
Related Topics investment coins healthcare $ciplans
/post/tweet::1947298213771587941